Keeps Biopharma Inc. (KOSDAQ:256940)
South Korea
· Delayed Price · Currency is KRW 15,980
-130 (-0.81%)
At close: May 30, 2025, 3:30 PM KST
Keeps Biopharma Revenue
In the year 2024, Keeps Biopharma had annual revenue of 127.58B KRW with 38.48% growth. Keeps Biopharma had revenue of 32.84B in the quarter ending December 31, 2024, with 5.87% growth.
Revenue
127.58B
Revenue Growth
+38.48%
P/S Ratio
2.23
Revenue / Employee
4.40B
Employees
31
Market Cap
304.84B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| Samsung Biologics | 4,898.69B |
| LG Energy Solution | 25.76T |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 15.28T |
| KB Financial Group | 14.93T |
| Kia Corporation | 109.25T |